Articles From: Zoës Kitchen to Present at Two Upcoming Investor Conferences to ZS Pharma Announces Publication of Results From Phase 3 Study of ZS-9 in Patients With Hyperkalemia in the New England Journal of Medicine


Zoës Kitchen (“Zoe’s Kitchen, Inc.”) (NYSE:ZOES) today announced that it will present at two investor conferences in January.
Sign-up for Zoës Kitchen to Present at Two Upcoming Investor Conferences investment picks
Zoetis Inc. (NYSE: ZTS) today announced that its Board of Directors has adopted a one-year shareholder rights plan (the “Plan”) and declared a dividend distribution of one preferred share purchase right (a “Right”) for each outstanding share of the Company’s common stock.
Sign-up for Zoetis Adopts One-Year Shareholder Rights Plan investment picks
Zoetis Inc. (NYSE:ZTS) today announced the appointment of Roman Trawicki as President of its Global Manufacturing and Supply organization.
Sign-up for Zoetis Announces Appointment of Roman Trawicki as President of Global Manufacturing and Supply investment picks
Zoetis Inc. (NYSE: ZTS), the world’s leading animal health company, today announced that its Board of Directors has authorized a $500 million share repurchase program as part of its capital allocation plans.
Sign-up for Zoetis Announces Authorization of $500 Million Share Repurchase Program investment picks
Animal health company Zoetis Inc. (ZTS) said Tuesday it's board has approved a share buyback program of $500 million.
Sign-up for Zoetis board approves $500 mln share buyback program investment picks
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a first quarter 2015 dividend payable to holders of the company’s common stock of $0.083 per share, an increase of 15% from the quarterly dividend rate paid in 2014.
Sign-up for Zoetis Declares First Quarter 2015 Dividend; Board Approves 15% Payment Increase investment picks
Zoetis Inc. (NYSE:ZTS), the world’s leading animal health company, today hosted its first-ever Investor Day, discussing with investors and analysts the company’s leadership position in the animal health industry and the strategy and initiatives underway that will drive growth and create value for shareholders.
Sign-up for Zoetis Outlines Strategy and Initiatives Underway to Drive Growth and Create Shareholder Value at Investor Day Meeting investment picks
Zoetis Inc. (ZTS) said on Wednesday that it will raise its quarterly dividend by 15% to 8.3 cents a share.
Sign-up for Zoetis raises quarterly dividend 15% investment picks
Zoetis Inc. (NYSE:ZTS) today reported its financial results for the third quarter of 2014.
Sign-up for Zoetis Reports Third Quarter 2014 Results investment picks
Shares of Zoetis (ZTS) extended losses in afternoon trade Tuesday, after the animal health company provided a downbeat profit and sales outlook for next year.
Sign-up for Zoetis shares fall further after downbeat 2015 outlook investment picks
Shares of Zoetis Inc. (ZTS) rallied Tuesday following a report that activist investor Bill Ackman has acquired a 10% stake in the animal-health products company.
Sign-up for Zoetis shares rally on report of Ackman stake investment picks
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (EST) on Wednesday, Feb.
Sign-up for Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2014 Financial Results investment picks
Zoetis Inc. (NYSE:ZTS) will participate in the Piper Jaffray 26th Annual Healthcare Conference on Tuesday, Dec.
Sign-up for Zoetis to Participate in Piper Jaffray 26th Annual Healthcare Conference investment picks
Zoetis Inc. (NYSE:ZTS) will participate in the 33 rd Annual J.P. Morgan Healthcare Conference on Wednesday, Jan.
Sign-up for Zoetis to Participate in the 33rd Annual J.P. Morgan Healthcare Conference investment picks
Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Animal & Dental Health Summit on Thursday, Dec.
Sign-up for Zoetis to Participate in the Bank of America Animal & Dental Health Summit investment picks
Zoetis Inc. (NYSE:ZTS) today announced an agreement to purchase animal health assets of Abbott for a purchase price of $255 million.
Sign-up for Zoetis to Purchase Assets of Abbott Animal Health investment picks
By Michael CaliaPlan also comes a week after Zoetis adopted a poison pill plan Zoetis Inc., the animal-health products maker at the center of the latest round of pharmaceutical deal talk, said Tuesday that its board has approved a $500 million share-buyback program.
Sign-up for Zoetis unveils $500 million buyback plan investment picks
Obtains global rights for treatment option in development for Dravet syndrome, a rare and catastrophic form of epilepsy that begins in infancy SAN DIEGO, Calif., Oct.
Sign-up for Zogenix Acquires U.K.-Based Brabant Pharma investment picks
SAN DIEGO, Jan.
Sign-up for Zogenix Provides Business Update investment picks
2014/11/6
Conference Call and Webcast Today, November 6, at 4:30 p.m. ET Recent Business Highlights Submitted a supplemental New Drug Application (sNDA) for a modified formulation with potential abuse deterrent properties of Zohydro ® ER (hydrocodone bitartrate) Extended-Release Capsules, CII, on September 30, with a target action date in late January 2015   Acquired Brabant Pharma, obtaining global rights for a Phase 3 product candidate with orphan drug designation in the U.S. and Europe for the treatment of Dravet syndrome    Exchanged waivers of regulatory exclusivity for extended-release hydrocodone products with Purdue Pharma, which includes $10 million in payments and potential sales royalties from Purdue    Signed a non-binding term sheet that is anticipated to provide a $20 million term loan plus an additional $4 million in a revolving line of credit Third Quarter 2014 Highlights Total prescriptions
Sign-up for Zogenix Reports Third Quarter 2014 Financial Results investment picks
SAN DIEGO, Dec.
Sign-up for Zogenix to Participate in Oppenheimer 25th Annual Healthcare Conference investment picks
SAN DIEGO, Nov.
Sign-up for Zogenix to Participate in Stifel 2014 Healthcare Conference investment picks
2015/1/12
Zoloto Resources Ltd ( OTC Pink:ZRSCF ) with milling operations in Ecuador has been in operation since November, 2014 on its Zumba project.
Sign-up for Zoloto Resources Continues Operations in Ecuador investment picks
2014/11/4
Zoloto Resources Ltd.
Sign-up for Zoloto Resources Ltd. Begins Operations in Ecuador investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Zoës Kitchen to Present at Two Upcoming Investor Conferences to ZS Pharma Announces Publication of Results From Phase 3 Study of ZS-9 in Patients With Hyperkalemia in the New England Journal of Medicine
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent